Norwegian pharmaceutical company Vistin Pharma ASA has sold its opioids and its contract tablet manufacturing business to TPI Enterprises Limited for NOK 100 million. “The sale of our opioids and CMO business allows the company to focus entirely on its core business, and strengthen our position as a leading global player in the growing metformin market. We are pleased with the agreed terms which put Vistin Pharma in a very strong financial position, with significant investment and divid...